Cognex Corporation $CGNX Shares Bought by Amundi

Amundi grew its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 4.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,125 shares of the scientific and technical instruments company’s stock after acquiring an additional 2,944 shares during the period. Amundi’s holdings in Cognex were worth $2,151,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Royal Bank of Canada lifted its position in shares of Cognex by 13.2% during the 1st quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock valued at $5,976,000 after acquiring an additional 23,326 shares during the period. Nomura Holdings Inc. lifted its position in shares of Cognex by 223.0% during the 1st quarter. Nomura Holdings Inc. now owns 73,509 shares of the scientific and technical instruments company’s stock valued at $2,193,000 after acquiring an additional 50,751 shares during the period. Magnetar Financial LLC acquired a new stake in shares of Cognex during the 1st quarter valued at approximately $678,000. Trexquant Investment LP lifted its position in shares of Cognex by 46.5% during the 1st quarter. Trexquant Investment LP now owns 636,867 shares of the scientific and technical instruments company’s stock valued at $18,998,000 after acquiring an additional 202,173 shares during the period. Finally, Jane Street Group LLC lifted its position in shares of Cognex by 526.1% during the 1st quarter. Jane Street Group LLC now owns 474,132 shares of the scientific and technical instruments company’s stock valued at $14,143,000 after acquiring an additional 398,408 shares during the period. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Sheila Marie Dipalma sold 2,000 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $45.03, for a total transaction of $90,060.00. Following the completion of the sale, the executive vice president directly owned 6,582 shares of the company’s stock, valued at $296,387.46. The trade was a 23.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CGNX shares. Citigroup reissued a “neutral” rating and set a $37.00 price objective (up from $30.00) on shares of Cognex in a research note on Monday, July 14th. UBS Group raised their price objective on shares of Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Melius raised shares of Cognex from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Thursday, July 10th. DA Davidson raised their price objective on shares of Cognex from $32.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, Robert W. Baird raised their price objective on shares of Cognex from $30.00 to $32.00 and gave the stock a “neutral” rating in a research note on Monday, June 16th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cognex currently has an average rating of “Moderate Buy” and an average price target of $42.31.

Cognex Stock Performance

CGNX stock opened at $44.95 on Friday. The stock has a market capitalization of $7.55 billion, a P/E ratio of 63.31 and a beta of 1.50. Cognex Corporation has a one year low of $22.67 and a one year high of $45.23. The company has a 50 day moving average price of $39.58 and a two-hundred day moving average price of $32.96.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million during the quarter, compared to analysts’ expectations of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. Cognex’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Research analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were paid a dividend of $0.08 per share. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. Cognex’s payout ratio is currently 45.07%.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.